














New tool uses UV light to control in.ammation
By Krishna Ramanujan
Black light does more than make
posters glow. Cornell researchers
have developed a chemical tool to
control in��ammation that is
activated by ultraviolet (UV) light.
The method will allow scientists to
study in��ammation and the
immune system, and may one day
prove e�ective as a targeted
therapy for in��ammatory diseases,
while minimizing side e�ects to
healthy tissues.
The researchers, who reported
their results in a study published in
October in the journal Chemical
Science, designed a small molecule
that is capable of controlling an
immune response when exposed to
UV light radiation.
“Currently, there aren’t a lot of tools
that are able to manipulate the
immune system in a spatio-temporal fashion,” said Pamela Chang, assistant professor of
microbiology and immunology, and the paper’s senior author. Bibudha Parasar, a graduate
student in Chang’s lab, is the paper’s �rst author.
“We are pushing the forefront of developing new technologies to control in��ammation and the
immune system, with the ultimate goal of being able to study these biological pathways and
perhaps develop therapies for in��ammatory diseases,” Chang said.
In��ammation is caused by the immune system as one of the body’s responses to eliminate
infectious pathogens and other foreign or dangerous agents. When in��ammation becomes
chronic, it can lead to a host of diseases, including asthma, multiple sclerosis, rheumatoid
arthritis, colitis and Crohn’s disease.
The researchers created a chemical probe that inhibits a reaction mediated by enzymes called
histone deacetylases (HDACs). These enzymes regulate genes that turn on when the immune
system is challenged and promote in��ammation. HDACs also have inhibitors that suppress this
in��ammatory response, and the probe speci�cally activates these inhibitors but only in the
presence of UV light. This is especially useful since HDACs are ubiquitous and have other






































“If you turned o� all the HDACs in the body, you would probably be hitting a lot of pathways that
you didn’t want to turn o�,” said Chang. “We can control when and where we turn o� the HDACs
using light. The idea is that you can actually target the tissue that has chronic in��ammation and
regulate it by selectively inhibiting HDACs in the tissue that’s a�ected.”
Photodynamic therapies are being developed and have existing infrastructure in the clinic for
the potential use of the new tool to inhibit in��ammation in patients with in��ammatory diseases,
Chang said.
The study was supported by a President’s Council of Cornell Women A�nito-Stewart Grant.
